Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147
Phase: N/A
Priority: Normal
Start: 01/22/19
End: 02/01/20
Due: 02/01/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses of J147 | NCT03838185 | Abrexa Pharmaceuticals, Inc. | user2@example.com | None | 2019-01-22 | 2020-02-01 | 2021-02-01 | - | - | 2025-07-14 |